Skip to main content
Start Project

Free field guide · PDF

EU IVDR Transition2026 Field Guide

The deadlines, the checkpoints, and the practice — with the transition work you need.

Need NB
80%
Checkpoints
3
End dates
2027–29

Sourced from verified 2026 publications.

Download the free guide

Enter your work email and we'll send the PDF straight to your inbox.

Professional review is required before business use. See our privacy policy.

What's inside

Five pages, zero fluff

Every figure in this guide traces to a named source — verified 2026 publications.

The deadlines

The deadlines: Class D → Dec 2027, Class C → Dec 2028, Class B / sterile A → Dec 2029 — all conditional.

The checkpoints

The checkpoints: QMS → NB application → signed NB agreement — per-class dates you cannot miss.

The practice

The practice: no-significant-change rules, supply-notification duties, and the 18–24-month queue.

Sources & scope

  • Aurevia QARA, The IVDR Transition Is Not Over: Key Deadlines and Common Pitfalls (LinkedIn, 2026).
  • sgs.com, Is Your Class C IVD Transition on Track? (Apr 2026).
  • tuvsud.com, In Vitro Diagnostic Regulation (IVDR).

This guide is market-access intelligence, not regulatory or legal advice. IVDR transition requirements, EUDAMED timelines, and notified-body practice change — professional review is required before business use.

Market Access Strategy Session

IVD on your 2026 roadmap? Start with the full picture.

A Market Access Strategy Session maps your IVDR route — checkpoint sequencing, NB strategy, and documentation planning.

Professional review is required before business use.